Incannex Healthcare Inc. (IXHL): Share Repurchases
$9.40M
Year ended 2026-06-30
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $9.40M | n/a | 2026-09-25, From 2025-07-01 |
| 2025-06-30 | $0 | n/a | 2026-09-25, From 2024-07-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | 2026-06-30 | $9.40M | n/a |
| Abbott Laboratories (ABT) | 2025-12-31 | $893.00M | -31.0% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $0 | n/a |
| Eli Lilly & Co (LLY) | 2025-12-31 | $4.11B | +64.3% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $5.95B | +144.8% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $16.31M | +84.1% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $5.08B | +289.3% |
| Lifevantage Corp (LFVN) | 2026-06-30 | $2.04M | -35.1% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $3.44B | +32.1% |
Compare IXHL, ABT, BMY, LLY side by side · Screen every company in Pharmaceutical Preparations ↗